Maricel Apuli - 16 Nov 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: Chief Accounting Officer
Signature: /s/ Maricel Apuli
Issuer symbol: BBIO
Transactions as of: 16 Nov 2025
Transactions value $: -$317,411
Form type: 4
Filing time: 18 Nov 2025, 19:23:28 UTC
Previous filing: 19 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Apuli Maricel	Chief Accounting Officer	C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO	/s/ Maricel Apuli	18 Nov 2025	0002058197

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Tax liability	-$317K	-4.78K	-3.49%	$66.39	132K	16 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,410 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.